ES2058687T3 - Composicion nutritiva y su procedimiento de preparacion. - Google Patents
Composicion nutritiva y su procedimiento de preparacion.Info
- Publication number
- ES2058687T3 ES2058687T3 ES90111519T ES90111519T ES2058687T3 ES 2058687 T3 ES2058687 T3 ES 2058687T3 ES 90111519 T ES90111519 T ES 90111519T ES 90111519 T ES90111519 T ES 90111519T ES 2058687 T3 ES2058687 T3 ES 2058687T3
- Authority
- ES
- Spain
- Prior art keywords
- composition
- amino acids
- mixtures
- preparation procedure
- essential
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Urology & Nephrology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE DESCRIBE UNA FORMULACION NUTRITIVA NUEVA COMPRENDIENDO MEZCLAS DE SALES MEZCLADAS FORMADAS ENTRE (ALFA)-QUETOACIDOS Y ACIDOS BASICOS L-AMINO, CUYA FORMULACION PROPORCIONA NUTRICION OPTIMA CUANDO SE CONSUME, CON UNA DIETA MUY BAJA EN PROTEINAS. LA COMPOSICION DE ESTA INVENCION CONTIENE MENOS COMPONENTES QUE OTRAS MEZCLAS UTILIZADAS HASTA AHORA, EN TANTO QUE SE MANTIENEN LAS PROPORCIONES DE LOS AMINOACIDOS ESENCIALES Y SEMIESENCIALES. LA COMPOSICION DE ESTA INVENCION TIENE UNA ESTABILIDAD TERMICA Y UN SABOR MEJORADOS, Y RESULTA DE UTILIDAD PARA EL TRATAMIENTO NUTRITIVO DE MAL FUNCIONAMIENTO RENAL CRONICO (UREMIA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/369,163 US4957938A (en) | 1989-06-21 | 1989-06-21 | Nutritional formulation for the treatment of renal disease |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2058687T3 true ES2058687T3 (es) | 1994-11-01 |
Family
ID=23454347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90111519T Expired - Lifetime ES2058687T3 (es) | 1989-06-21 | 1990-06-19 | Composicion nutritiva y su procedimiento de preparacion. |
Country Status (9)
Country | Link |
---|---|
US (1) | US4957938A (es) |
EP (1) | EP0405295B1 (es) |
JP (1) | JPH0331211A (es) |
KR (1) | KR910000140A (es) |
AT (1) | ATE91392T1 (es) |
AU (1) | AU627041B2 (es) |
CA (1) | CA2019472A1 (es) |
DE (1) | DE69002201T2 (es) |
ES (1) | ES2058687T3 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5374651A (en) * | 1991-09-27 | 1994-12-20 | Board Of Regents, The University Of Texas System | Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives |
WO1993005780A1 (en) * | 1991-09-27 | 1993-04-01 | Board Of Regents, The University Of Texas System | Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies |
US5234696A (en) * | 1991-12-27 | 1993-08-10 | Abbott Laboratories | Method of producing tablets, tablets produced thereby, and method of treatment using same |
US5891459A (en) * | 1993-06-11 | 1999-04-06 | The Board Of Trustees Of The Leland Stanford Junior University | Enhancement of vascular function by modulation of endogenous nitric oxide production or activity |
US5576287A (en) * | 1994-04-29 | 1996-11-19 | Wake Forest University | Method for treating acute renal disease and failure |
DE69530067T2 (de) * | 1994-10-07 | 2004-01-29 | Firmenich & Cie | Aromazusammensetzungen und aromatisierungsverfahren |
AUPN115095A0 (en) * | 1995-02-15 | 1995-03-09 | Butt, Henry Lawrence | Analysis of and compositions and methods for the treatment of disease |
FR2775901B1 (fr) * | 1998-03-13 | 2000-07-21 | Logeais Labor Jacques | Sels de cetoacides et de derives amines, et leur utilisation pour la preparation de medicaments |
AU3221599A (en) * | 1998-04-03 | 1999-10-25 | Daily Wellness Company, The | Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation |
US20050196470A9 (en) * | 1998-04-03 | 2005-09-08 | Wuh Hank C | Method and composition for enhancing sexual desire |
US6288116B1 (en) | 1998-05-13 | 2001-09-11 | Novartis Nutrition Ag | Method of administration of a nutritional product to a person having renal failure |
JP2003501393A (ja) * | 1999-06-05 | 2003-01-14 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ | 心臓血管細胞増殖を阻害するための方法および組成物 |
US7696219B2 (en) * | 2000-09-27 | 2010-04-13 | Everett Laboratories, Inc. | Method and composition for supplementation of nutritional deficiences in renal patients |
US6995166B1 (en) | 2000-09-27 | 2006-02-07 | Everett Laboratories, Inc. | Method and composition for supplementation of nutritional deficiencies in renal patients |
US6497885B2 (en) * | 2000-12-22 | 2002-12-24 | The Daily Wellness Company | Method and composition for improving fertility health in female and male animals and humans |
US6989164B2 (en) * | 2000-12-22 | 2006-01-24 | The Daily Wellness Company | Method and composition for improving male fertility health |
FR2822704B1 (fr) * | 2001-03-29 | 2005-02-18 | Chiesi Sa | Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments |
WO2002081020A2 (en) * | 2001-04-04 | 2002-10-17 | Critical Therapeutics, Inc. | Method for preventing acute renal failure |
ITTO20020672A1 (it) * | 2002-07-26 | 2004-01-26 | Medestea Res And Production S | Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale |
EP1737482A4 (en) * | 2004-03-01 | 2010-09-15 | Lumen Therapeutics Llc | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES |
ES2882278T3 (es) * | 2018-07-31 | 2021-12-01 | Evonik Operations Gmbh | Mezclas de cetoácidos de cadena ramificada (BCKA) y procedimiento para la producción de tales mezclas |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1511302A (en) * | 1974-04-15 | 1978-05-17 | Univ Johns Hopkins | Pharmaceutical compositions comprising amino acid analogues |
US4100293A (en) * | 1974-04-15 | 1978-07-11 | The Johns Hopkins University | Treatment of hepatic disorders with therapeutic compositions comprising keto analogs of essential amino acids |
US4320146A (en) * | 1978-03-17 | 1982-03-16 | The Johns Hopkins University | Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids |
US4296127A (en) * | 1979-04-18 | 1981-10-20 | The Johns Hopkins University | Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof |
US4352814A (en) * | 1979-04-18 | 1982-10-05 | The Johns Hopkins University | Treatment of hepatic and renal disorders with mixed salts of essential or semi-essential amino acids and nitrogen-free analogs |
US4677121A (en) * | 1985-01-22 | 1987-06-30 | The Johns Hopkins University | Method of inhibiting muscle protein degradation |
US4752619A (en) * | 1985-12-23 | 1988-06-21 | The Johns Hopkins University | Nutritional supplement for treatment of uremia |
FR2615734B1 (fr) * | 1987-05-27 | 1989-12-01 | Synthelabo | Compositions pharmaceutiques contenant un melange de sels de cetoacides et d'amino-acides utiles pour le traitement de l'uremie |
-
1989
- 1989-06-21 US US07/369,163 patent/US4957938A/en not_active Expired - Fee Related
-
1990
- 1990-06-19 ES ES90111519T patent/ES2058687T3/es not_active Expired - Lifetime
- 1990-06-19 EP EP90111519A patent/EP0405295B1/en not_active Revoked
- 1990-06-19 DE DE90111519T patent/DE69002201T2/de not_active Expired - Fee Related
- 1990-06-19 AT AT90111519T patent/ATE91392T1/de not_active IP Right Cessation
- 1990-06-20 AU AU57673/90A patent/AU627041B2/en not_active Ceased
- 1990-06-21 CA CA002019472A patent/CA2019472A1/en not_active Abandoned
- 1990-06-21 KR KR1019900009129A patent/KR910000140A/ko not_active Application Discontinuation
- 1990-06-21 JP JP2163958A patent/JPH0331211A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JPH0331211A (ja) | 1991-02-12 |
US4957938A (en) | 1990-09-18 |
ATE91392T1 (de) | 1993-07-15 |
EP0405295A3 (en) | 1991-03-27 |
DE69002201D1 (de) | 1993-08-19 |
KR910000140A (ko) | 1991-01-29 |
EP0405295A2 (en) | 1991-01-02 |
DE69002201T2 (de) | 1994-01-05 |
EP0405295B1 (en) | 1993-07-14 |
AU5767390A (en) | 1991-01-03 |
CA2019472A1 (en) | 1990-12-21 |
AU627041B2 (en) | 1992-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2058687T3 (es) | Composicion nutritiva y su procedimiento de preparacion. | |
Margen et al. | Studies in calcium metabolism. I. The calciuretic effect of dietary protein | |
DK0567433T4 (da) | Oralt indtagelige ernæringspræparater med forbedret smag | |
JPS56110617A (en) | Nutrient composition for young child | |
IL162244A (en) | Infant formula compositions comprising increased amounts of alpha-lactalbumin | |
PT614616E (pt) | Composicao para o tratamento de pacientes com doenca hepatica | |
ES2062231T3 (es) | Mezclas de proteinas, peptidos y aminoacidos. | |
ATE113441T1 (de) | Proteinhydrolysaten. | |
NO865217D0 (no) | Fremgangsmaate for fremstilling av anti-uremiapreparater. | |
CA2326148A1 (en) | Method for providing glutamine | |
AU566901B2 (en) | Lysine solutions for feedstuff supplement | |
AU1971988A (en) | Pharmaceutical compositions for the treatment of uraemia | |
BR9814766A (pt) | Formulação de revitalização | |
JPS5533446A (en) | Amino acid transfusion for postoperative patient | |
JPS6460354A (en) | Quality improver composition for sausage | |
Diehl et al. | Vitamin E deficiency in rabbits receiving a high PUFA diet with and without a non-absorbable antioxidant II. Incorporation of 14 C-labelled glycine and l-leucine into liver and plasma proteins | |
MD930059A (ro) | Produs alimentar "Nectarină" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 405295 Country of ref document: ES |